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Despite very early in ovo metabolism by embryos, maternal yolk steroids transferred 
during oogenesis can affect offspring phenotype
We manipulated etiocholanolone levels after laying and assessed nest success, structural 
growth, and physiological development throughout nestling development
No detectable changes were found in early embryonic development of eggs when injected 
with etiocholanolone, but little is known about potential lasting phenotypic effects
Chicks from all treatments exhibited statistically similar patterns of somatic growth across 
early development
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• This experiment was performed on European starlings 
from May 29th, 2019 until July 11th, 2019.
• Eggs, once laid, were injected with 5 ng (+ 2 S.D.) of 
etiocholanolone in 5 µL of sesame oil, 5 µL of oil alone, 
or left uninjected, and all eggs were then allowed to 
complete natural incubation.
• Glucose was measured in the field with a home glucose 
meter and test strips (ReliOn-micro).5
• Corticosterone levels were measured using a 
corticosterone enzyme immunoassay kit (ArborAssays).6
• Hemoglobin concentration was measured using the 
cyanmethemoglobin method.7,8 
• Nest was included as a random effect in relevant 
statistical analyses.
• In eggs of European starlings (Sturnus vulgaris), exogenously applied testosterone is readily converted to etiocholanolone within 
the first 12 hours of incubation. 4
• Exogenous etiocholanolone administration, at egg laying, does not significantly effect the growth of embryos or extraembryonic 
membranes after five days of incubation.4
• This suggests that metabolism of testosterone to etiocholanolone may be an inactivation pathway that buffers the embryo from the
effects of maternal steroids.4
• Outside of early embryonic development, little is know about the affects of etiocholanolone on avian development. Our 
pilot study aimed to examine the effects of in ovo injection of etiocholanolone during an extended assessment of early 
starling development throughout the first 15 days of nestling development.
• Wing length, tarsus length, and nestling mass increased in expected patterns across devolvement, but remained statistically 
similar between treatments for all three measured parameters of somatic growth.
• Corticosterone and blood glucose levels did not significantly differ among treatments across nestling development. 
• Nestlings at 5 days of age displayed significantly higher hematocrit levels in the etiocholanolone and oil treatments than the 
uninjected treatment, but were not significantly different at ages 10 and 15. Sesame oil may have provided additional nutrients for 
injected eggs that potentially aided in hematocrit production early in development.
• Hemoglobin levels generally increased during early development, and did not differ significantly among treatments. 
Above and throughout: ✽ indicates a treatment group that differs from all other treatments.
• No significant differences were observed in overall nest hatching success (having at least one egg in the nest hatch) between
the three treatments.
• Within these nests, the uninjected treatment yielded a significantly higher percentage of hatched eggs than both the 
etiocholanolone and oil treatments (p = 0.0337 and p = 0.0290, respectively), and the injection treatments were not significantly 
different from each other. 
• Would a greater dose or alternate route of 
administration of etiocholanolone elicit 
physiological effects? 
• What other steroid metabolites might be active in 
early nestling development?
• Would eggs or nestlings from earlier in the 
breeding season be affected differently by in ovo 
treatment?
• Is the signal transduction mechanism by which 
etiocholanolone acts to affect target tissues in 
adulthood found in developing embryos?
• Structural growth, blood glucose, corticosterone, and 
hemoglobin concentrations were unaffected by treatment. 
• Injection of both oil and etiocholanolone affected hematocrit at 
day 5, suggesting that oil itself, not etiocholanolone, was the 
cause of increased hematocrit levels.
• Nest hatching success was similar among treatments, although 
our method of injection may need refinement, as egg injection 
lead to a significantly lower hatch rate.
• We found no evidence that embryonic exposure to increases in 
etiocholanolone influences nestling development, which 
supports the idea that embryonic steroid metabolism buffers 
embryos from maternal steroids.
• Maternally derived steroids transferred to egg yolks during oogenesis can alter offspring phenotypes. 1
• These yolk steroids can be locally modulated by embryos via metabolism, such as the enzymatic conversion of testosterone to 
etiocholanolone. 1,2
• However, it is unclear whether metabolites, like etiocholanolone, can alter offspring phenotype, or are byproducts of an 
inactivation shunt that buffers developing young against early maternal steroids. 3,4
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This legend is used throughout the poster
Injecting eggs did not significantly reduce nest success during incubation, but did 
significantly reduce the percentage of eggs that hatched
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